ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
Public
All
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

ST PHARM's Public Release

  • All
  • Media Focus
  • ST PHARM News
Media FocusST PHARM, signs $9.2million contract to supply MRI contrast medium raw materialsJan 11, 2023
ST PHARM NewsST PHARM participated in 2023 JP Morgan healthcare conferenceJan 4, 2023
ST PHARM NewsST PHARM, 2022 KCGS ESG rating 'B+'Dec 5, 2022
ST PHARM NewsST PHARM, 2022 Sustinvest ESG Rating 'AA'Nov 18, 2022
ST PHARM NewsST PHARM Participated in 10th International mRNA Health ConferenceOct 31, 2022
ST PHARM NewsST PHARM, Participated in CPHI 2022 FrankfrutOct 17, 2022
Media FocusST PHARM, Top 10 CDMOs In APAC 2022Sep 26, 2022
ST PHARM NewsST PHARM, Frost & Sullivan Best Practices Virtual Awards CeremonyAug 17, 2022
Media FocusST PHARM Present Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022Aug 4, 2022
ST PHARM NewsST PHARM, FDA cGMP certification for oligo plant in Korea, for the first time in AsiaAug 2, 2022
Media FocusST PHARM Scores FDA's cGMP Certification (NAI) for Oligo PlantAug 2, 2022
Media FocusST PHARM's Banwol Campus 'Oligo Manufacturing Plants' cGMP Certified by USA FDAAug 1, 2022
Media FocusST PHARM's Cutting-edge Technology to Reduce the Cost of Promising DrugJul 28, 2022
1of3
HOMEPublicPR (Public Relations)News roomAll
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
© 2023 ST Pharm. All rights reserved.
  • Sitemap
  • Contact